A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Shekalaghe, Seif A ^a,b,c   Drakeley, Chris ^d   Van Den Bosch, Sven ^b   Ter Braak, Roel ^b   Van Den Bijllaardt, Wouter ^b   Mwanziva, Charles ^a   Semvua, Salimu ^a   Masokoto, Alutu ^a   Mosha, Frank ^a   Teelen, Karina ^b   Hermsen, Rob ^b   Okell, Lucy ^e   Gosling, Roly ^d   Sauerwein, Robert ^b   Bousema, Teun ^b,d  

^a KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c IFAKARA HEALTH INSTITUTE   (Tanzania)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; PLACEBO; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; MICROSCOPY; PARASITE PREVALENCE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE DRUG DOSE; SKIN MANIFESTATION; TANZANIA; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG COMBINATION; ENDEMIC DISEASE; METHODOLOGY; MIDDLE AGED; PARASITEMIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; MALARIA; MALE; MICROSCOPY; MIDDLE AGED; PARASITEMIA; PLACEBOS; PRIMAQUINE; PYRIMETHAMINE; SULFADOXINE; TANZANIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052027129     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-247     Document Type: Article

References (71)

1. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, PLoSMed 2005 2 330
2. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, Khatib R, Al Mafazy AW, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, Kaneko A, Bjorkman A, PLoSMed 2007 4 309
3. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CR, Marsh K, Lancet 2008 372 1555 1562 10.1016/S0140-6736(08)61655-4 18984188
4. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ, Sesay SS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T, Bojang KA, Whittle HC, Greenwood BM, Conway DJ, Lancet 2008 372 1545 1554 10.1016/S0140-6736(08)61654-2 18984187
5. Rapid assessment of malaria transmission using age-specific sero-conversion rates. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C, PLoS One 2009 4 6083 10.1371/journal.pone.0006083 19562032
6. The decline in paediatric malaria admissions on the coast of Kenya. Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, Peshu N, Marsh K, Snow RW, Malar J 2007 6 151 10.1186/1475-2875-6-151 18005422
7. Changes in the burden of malaria in sub-Saharan Africa. O'Meara WP, Mangeni JN, Steketee R, Greenwood B, Lancet Infect Dis 2010 10 545 555 10.1016/S1473-3099(10)70096-7 20637696
8. World Health Organization, Malaria elimination: a field manual for low and moderate endemic countries 2007
9. Shrinking the malaria map from the outside in. Roberts L, Science 2010 328 849 851 10.1126/science.328.5980.849 20466920
10. Effectiveness of malaria control during changing climate conditions in Eritrea, 1998-2003. Graves PM, Osgood DE, Thomson MC, Sereke K, Araia A, Zerom M, Ceccato P, Bell M, Del Corral J, Ghebreselassie S, Brantley EP, Ghebremeskel T, Trop Med Int Health 2008 13 218 228 10.1111/j.1365-3156.2007.01993.x 18304268 (Pubitemid 351316973)
11. Marked increase in child survival after four years of intensive malaria control. Kleinschmidt I, Schwabe C, Benavente L, Torrez M, Ridl FC, Segura JL, Ehmer P, Nchama GN, Am J Trop Med Hyg 2009 80 882 888 19478243
12. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Barnes KI, Chanda P, Ab Barnabas G, Malar J 2009 8 Suppl 1 8. 19917078
13. Artemisinin-based combination therapy for treating uncomplicated malaria. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P, Cochrane Database Syst Rev 2009 D007483
14. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW, J Infect Dis 2006 193 1151 1159 10.1086/503051 16544256
15. The role of antimalarial drugs in eliminating malaria. White NJ, Malar J 2008 7 Suppl 1 8 10.1186/1475-2875-7-S1-S8 19091042
16. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, Pinder M, Doherty T, Sutherland C, Walraven G, Milligan P, J Infect Dis 2001 183 1254 1259 10.1086/319689 11262208 (Pubitemid 32281565)
17. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of Co-Artemether. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GA, PLoS Med 2005 2 92 10.1371/journal.pmed.0020092 15839740 (Pubitemid 40721079)
18. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC, PLoS Med 2008 5 226 discussion e226 10.1371/journal.pmed. 0050226 19067479
19. Effects of artemisinin derivatives on malaria transmissibility. Price RN, Nosten F, Luxemburger C, terKuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, Lancet 1996 347 1654 1658 10.1016/S0140-6736(96)91488-9 8642959 (Pubitemid 26177386)
20. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F, Van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, Ter Kuile F, Looareesuwan S, White NJ, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185 (Pubitemid 30459588)
21. Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. Drakeley CJ, Akim NI, Sauerwein RW, Greenwood BM, Targett GA, Trans R Soc Trop Med Hyg 2000 94 472 476 10.1016/S0035-9203(00) 90056-7 11132369
22. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA, Trends Parasitol 2006 22 424 430 10.1016/j.pt.2006.07.001 16846756 (Pubitemid 44176410)
23. Infectivity of asymptomatic Plasmodium-infected human populations to Anopheles dirus mosquitoes in western Thailand. Coleman RE, Kumpitak C, Ponlawat A, Maneechai N, Phunkitchar V, Rachapaew N, Zollner G, Sattabongkot J, JMedEntomol 2004 41 201 208 (Pubitemid 38403261)
24. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW, Malar J 2004 3 18 10.1186/1475-2875-3- 18 15202944 (Pubitemid 39319755)
25. High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. Boudin C, Olivier M, Molez JF, Chiron JP, Ambroise-Thomas P, Am J Trop Med Hyg 1993 48 700 706 8517489 (Pubitemid 23187202)
26. Substantial contribution of sub-microscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. Ouedraogo AL, Bousema T, Schneider P, de Vlas SJ, Ilboudo-Sanogo E, Cuzin-Ouattara N, Nebie I, Roeffen W, Verhave JP, Luty AJ, Sauerwein R, PLoS One 2009 4 8410 10.1371/journal.pone.0008410 20027314
27. Gametocytes: insights gained during a decade of molecular monitoring. Babiker HA, Schneider P, Reece SE, Trends Parasitol 2008 24 525 530 10.1016/j.pt.2008.08.001 18801702
28. Sub-microscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania. Shekalaghe SA, Bousema JT, Kunei KK, Lushino P, Masokoto A, Wolters LR, Mwakalinga S, Mosha FW, Sauerwein RW, Drakeley CJ, Trop Med Int Health 2007 12 547 553 10.1111/j.1365-3156.2007. 01821.x 17445146 (Pubitemid 46631150)
29. Sub-microscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Schneider P, Bousema JT, Gouagna LC, Otieno S, van dV, Omar SA, Sauerwein RW, Am J Trop Med Hyg 2007 76 470 474 17360869 (Pubitemid 351627738)
30. Sub-microscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. Okell LC, Ghani AC, Lyons E, Drakeley CJ, J Infect Dis 2009 200 1509 1517 10.1086/644781 19848588
31. Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. Abdel-Wahab A, Abdel-Muhsin AM, Ali E, Suleiman S, Ahmed S, Walliker D, Babiker HA, J Infect Dis 2002 185 1838 1842 10.1086/340638 12085337 (Pubitemid 34615485)
32. Mass administrations of antimalarial drugs. von Seidlein L, Greenwood BM, Trends Parasitol 2003 19 452 460 10.1016/j.pt.2003.08.003 14519583 (Pubitemid 38366142)
33. Malaria eradication on islands. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A, Lancet 2000 356 1560 1564 10.1016/S0140-6736(00)03127- 5 11075770
34. A malaria eradication experiment in the highlands of Kigezi (Uganda). Zulueta J, Kafuko GW, McCrae AW, Cullen JR, Pedrsen CK, Wasswa DF, East Afr Med J 1964 41 102 120 14133988
35. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Song J, Socheat D, Tan B, Dara P, Deng C, Sokunthea S, Seila S, Ou F, Jian H, Li G, Malar J 2010 9 57 10.1186/1475-2875-9-57 20175930
36. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. von Seidlein L, Walraven G, Milligan PJ, Alexander N, Manneh F, Deen JL, Coleman R, Jawara M, Lindsay SW, Drakeley C, De Martin C, Olliaro P, Bennett S, Schim van der Loeff AU, Okunoye K, Targett GA, McAdam KP, Doherty JF, Greenwood BM, Pinder M, Trans R Soc Trop Med Hyg 2003 97 217 225 (Pubitemid 37265637)
37. Primaquine clears sub-microscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T, PLoS One 2007 2 1023 10.1371/journal.pone.0001023 17925871 (Pubitemid 351486737)
38. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. Okell LC, Griffin J, Kleinschmidt I, Hollingsworth TD, Churcher T, White M, Bousema T, Drakeley CJ, Ghani A, PLoS One 2011 6 20179 10.1371/journal.pone.0020179 21629651
39. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Bousema T, Drakeley C, Clin Microbiol Rev 2011 24 377 410 10.1128/CMR.00051-10 21482730
40. Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. Oesterholt MJ, Bousema JT, Mwerinde OK, Harris C, Lushino P, Masokoto A, Mwerinde H, Mosha FW, Drakeley CJ, Malar J 2006 5 98 10.1186/1475-2875-5-98 17081311 (Pubitemid 44730496)
41. Vector density gradients and the epidemiology of urban malaria in Dakar, Senegal. Trape JF, Lefebvre-Zante E, Legros F, Ndiaye G, Bouganali H, Druilhe P, Salem G, Am J Trop Med Hyg 1992 47 181 189 1354414
42. Dispersal and survival of Anopheles funestus and A. gambiae s.l. (Diptera: Culicidae) during the rainy season in southeast Tanzania. Takken W, Charlwood JD, Billingsley PF, Gort G, Bull Entomol Res 1998 88 561 566 10.1017/S0007485300026080 (Pubitemid 28514628)
43. Spatial targeting of interventions against malaria. Carter R, Mendis KN, Roberts D, Bull World Health Organ 2000 78 1401 1411 11196487 (Pubitemid 32105024)
44. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S, Koenderink JB, Luty AJ, Whitty CJ, Drakeley C, Sauerwein RW, Bousema T, Antimicrob Agents Chemother 2010 54 1762 1768 10.1128/AAC.01135-09 20194698
45. Taking a medical history and using a colour scale during clinical examination of pallor improves detection of anaemia. Chowdhury ME, Chongsuvivatwong V, Geater AF, Akhter HH, Winn T, Trop Med Int Health 2002 7 133 139 10.1046/j.1365-3156.2002.00837.x 11841703 (Pubitemid 34146790)
46. Rapid and simple method for purification of nucleic acids. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der NJ, J Clin Microbiol 1990 28 495 503 1691208 (Pubitemid 20078123)
47. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HD, Kager PA, Malar J 2008 7 237 10.1186/1475-2875-7-237 19017387
48. Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Schneider P, Schoone G, Schallig H, Verhage D, Telgt D, Eling W, Sauerwein R, Mol Biochem Parasitol 2004 137 35 41 10.1016/j.molbiopara.2004.03.018 15279949 (Pubitemid 38987940)
49. Influence of centers for disease control light trap position, relative to a human-baited bed net, on catches of Anopheles gambiae and Culex quinquefasciatus in Tanzania. Mboera LE, Kihonda J, Braks MA, Knols BG, Am J Trop Med Hyg 1998 59 595 596 9790436 (Pubitemid 28480717)
50. Field evaluation of enzyme-linked immunosorbent assays for Plasmodium falciparum and Plasmodium vivax sporozoites in mosquitoes (Diptera: Culicidae) from Papua New Guinea. Wirtz RA, Burkot TR, Graves PM, Andre RG, J Med Entomol 1987 24 433 437 3305949 (Pubitemid 18076548)
51. An estimation of the entomological inoculation rate for Ifakara: a semi-urban area in a region of intense malaria transmission in Tanzania. Drakeley C, Schellenberg D, Kihonda J, Sousa CA, Arez AP, Lopes D, Lines J, Mshinda H, Lengeler C, Armstrong-Schellenberg J, Tanner M, Alonso P, Trop Med Int Health 2003 8 767 774 10.1046/j.1365-3156.2003.01100.x 12950662 (Pubitemid 37108476)
52. Prospects for the control of neglected tropical diseases by mass drug administration. Smits HL, Expert Rev Anti Infect Ther 2009 7 37 56 10.1586/14787210.7.1.37 19622056
53. Revisiting the basic reproductive number for malaria and its implications for malaria control. Smith DL, McKenzie FE, Snow RW, Hay SI, PLoS Biol 2007 5 42 10.1371/journal.pbio.0050042 17311470 (Pubitemid 46422972)
54. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C, Malar J 2010 9 136 10.1186/1475-2875-9-136 20497536
55. Antimalarial drug toxicity: a review. Taylor WR, White NJ, Drug Saf 2004 27 25 61 14720085 (Pubitemid 38186936)
56. Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester. Clark RL, Reprod Toxicol 2009 28 285 96 10.1016/j.reprotox.2009.05.002 19447170
57. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. De Martin S, von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B, Trop Med Int Health 2001 6 442 448 10.1046/j.1365-3156. 2001.00723.x 11422958 (Pubitemid 32525662)
58. Changes in malaria incidence after mass drug administration in Nicaragua. Garfield RM, Vermund SH, Lancet 1983 2 500 503 6136655 (Pubitemid 13040011)
59. The Garki Project. Research on the epidemiology and control of malaria in the Sudan savannah of West Africa. Molineaux L, Gramiccia G, WHO 1980
60. A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Kaneko A, Acta Trop 2010 114 177 183 10.1016/j.actatropica.2010.01.012 20132788
61. Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Mwanziva C, Shekalaghe S, Ndaro A, Mengerink B, Megiroo S, Mosha F, Sauerwein R, Drakeley C, Gosling R, Bousema T, Malar J 2008 7 232 10.1186/1475-2875-7-232 18986520
62. A progressive declining in the burden of malaria in north-eastern Tanzania. Mmbando BP, Vestergaard LS, Kitua AY, Lemnge MM, Theander TG, Lusingu JP, Malar J 2010 9 216 10.1186/1475-2875-9-216 20650014
63. Predicting changing malaria risk after expanded insecticide-treated net coverage in Africa. Smith DL, Hay SI, Noor AM, Snow RW, Trends Parasitol 2009 25 511 516 10.1016/j.pt.2009.08.002 19744887
64. Malaria control needs mass distribution of insecticidal bednets. Teklehaimanot A, Sachs JD, Curtis C, Lancet 2007 369 2143 2146 10.1016/S0140-6736(07)60951-9 17597200 (Pubitemid 46977439)
65. Strategies towards Plasmodium falciparum malaria elimination in Africa using currently available tools. Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W, Bousema T, Drakeley CJ, Ferguson NM, Basanez M-G, Ghani AC, PLoS Med 2010 6 20179
66. Presumptive treatment of fever cases as malaria: help or hindrance for malaria control? Gosling R, Drakeley CJ, Mwita A, Chandramohan D, MalarJ 2008 7 132 10.1186/1475-2875-7-132
67. Azithromycin for treating uncomplicated malaria. van Eijk AM, Terlouw DJ, Cochrane Database Syst Rev 2011 2 D006688 21328286
68. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J, Arens T, Beckers P, van Gemert G, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q, Roeffen W, Snounou G, Renia L, van der Ven A, Hermsen CC, Sauerwein RW, Lancet 2011 377 1770 1776 10.1016/S0140-6736(11)60360-7 21514658
69. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, Lilley K, Krause D, Vallely A, Johnson ML, Gatton ML, Shanks GD, Cheng Q, Malar J 2010 9 254 10.1186/1475-2875-9-254 20822506
70. Malaria on isolated Melanesian islands prior to the initiation of malaria elimination activities. PMISG, Malar J 2010 9 218 20659316
71. Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. Falk N, Maire N, Sama W, Owusu-Agyei S, Smith T, Beck HP, Felger I, Am J Trop Med Hyg 2006 74 944 950 16760501 (Pubitemid 351627397)